FDA Inspection 1174486 — Stephane de Botton, M.D.
The FDA completed an inspection of Stephane de Botton, M.D. on July 1, 2022 in Villejuif. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 1, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Villejuif (France)
Additional Details
Clinical Investigator (CI)